Author(s):
Shashank Lavkush Shukla, Sudarshan E. Behere
Email(s):
vedants175@gmail.com , sudarshanbehere22@gmail.com
DOI:
10.52711/2321-5836.2025.00010 
Address:
Shashank Lavkush Shukla, Sudarshan E. Behere
Department of Pharmacology, JSPM Sudhakarrao Naik Institute of Pharmacy, Pusad, Dist. Yavatmal, Maharashtra 445204, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 1,
Year - 2025
ABSTRACT:
AI-powered systems can expedite the drug discovery process by examining vast amounts of medical data, identifying potential therapeutic targets, and forecasting the advantages of novel pharmacological approaches. Recent breakthroughs in scientific research have allowed scientists to develop medications specifically designed for certain groups of individuals. By employing computer vision, researchers can examine vast amounts of medical data, and they can identify existing drugs that may be suitable for treating specific medical conditions. AI streamlines the medical development process and lowers costs by repurposing medications that have already received approval. AI systems rely on data from early-stage and clinical trials to forecast different pharmacological attributes. They can accomplish this by utilizing artificial intelligence (AI) methods to examine vast amounts of data and pinpoint chemical markers that indicate both effectiveness and potential hazards. By integrating artificial intelligence into all aspects of their operations, pharmaceutical companies have the potential to triple their profits, surpassing their current levels. We expect that by 2030, companies will wholeheartedly adopt the emerging approach and acknowledge it as an essential component of their business strategies. As AI technology progresses, it is anticipated to result in the creation of more complex and accurate medication interactions. The collaboration between healthcare experts and researchers will propel advancements in AI technology, empowering drugstores to cater to the changing demands of their customers. The incorporation of AI in the pharmaceutical supply chain presents an opportunity to improve precision and efficiency by optimizing workflows, identifying new possibilities, and enabling employees to concentrate on more significant responsibilities. It is important to look forward to many activities. Artificial intelligence is also used in the evaluation of diseases and biomarkers. We describe different research models, general methods, and how they are used in drug research.
Cite this article:
Shashank Lavkush Shukla, Sudarshan E. Behere. Artificial Intelligence in Pharmacology Research. Research Journal of Pharmacology and Pharmacodynamics. 2025; 17(1):59-8. doi: 10.52711/2321-5836.2025.00010
Cite(Electronic):
Shashank Lavkush Shukla, Sudarshan E. Behere. Artificial Intelligence in Pharmacology Research. Research Journal of Pharmacology and Pharmacodynamics. 2025; 17(1):59-8. doi: 10.52711/2321-5836.2025.00010 Available on: https://rjppd.org/AbstractView.aspx?PID=2025-17-1-10
REFERENCES:
1. Chaturvedula A, Calad-Thomson S, Liu C, Sale M, Gattu N, Goyal N. Artificial intelligence and pharmacometrics: time to embrace, capitalize, and advance? CPT Pharmacomet Syst Pharmacol. 2019; 8:440. https:// doi. org/ 10. 1002/ psp4. 12418.
2. Murali N, Sivakumaran N. Artificial intelligence in healthcare–a review. J Mod Comput Inf Commun Technol. 2018; 1:103–10. https:// doi. org/ 10. 13140/ RG.2. 2. 27265. 92003.
3. Jabeen A, Ranganathan S. Applications of machine learning in GPCR bioactive ligand discovery. A machine learning model for classifying G-protein-coupled receptors as. Curr Opin Struct Biol. 2019; 55:66–76. https:// doi. org/ 10. 1016/j. sbi. 2019. 03. 022D.
4. A Brief Review on Nanorobotics Applications in Medicine and Future Prospects.
5. Applications of Robotics in Urology- A Review.
6. Target Discovery and Validation: Advances in Molecular Pharmacology.
7. Recent advances in Pharmacology and Toxicology of Phytopharmaceuticals.
8. Nanopharmacology: A Novel Approach in Therapeutics.
9. Chronopharmaceutics: A Clinically Relevant Approach to Drug Delivery.
10. A review on Infectious Diseases and their Importance in Developing Biological Databases.
11. Immunobioinformatics of Rabies Virus in Various Countries of Asia: Glycoprotein Gene.
12. Did the SARS-CoV-2 Come from Wild, Mutagenic or Artificial Type? Complete Genome Analysis.
13. Artifical Intelligence in E-commerce: Applications, Implications and Challenges.
14. Objective Monitoring of Cardiovascular Biomarkers using Artificial Intelligence (AI).
15. Explicating Artificial Intelligence: Applications in Medicine and Pharmacy.
16. A Novel Study of Machine Learning Algorithms for Classifying Health Care Data.
17. Drug discovery for COVID-19 and related mutations using artificial intelligence.
18. The Era of Artificial Intelligence in Pharmaceutical Industries - A Review.
19. Biomarkers: An Emerging Tool for Diagnosis of a Disease and Drug Development.
20. Review on Immuno-Oncology Agents for Cancer Therapy.
21. Biomarker Genes for Gynaecological Cancers.
22. Analysis of the Genotypic Distribution of Virulence and Antibiotic Resistance Biomarkers of Listeria Species in-silico.
23. Genomic Studies of Symbiodinium spp. to understand Coral Reef Resilience in India -A review.
24. A Review of the Pharmacological properties of potential drugs for the treatment of stuttering from the past to the future.
25. Discovery of a new Drug: A Fundamental Review.
26. Benzimidazole: An important Scaffold in Drug Discovery.
27. Antioxidant Assays in Pharmacological Research.